​

Prime Medicine (PRME) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Prime Medicine Revenue Highlights

Latest Revenue (Y)

$2.98M

Latest Revenue (Q)

$1.11M

Main Segment (Y)

Reportable Segment

Prime Medicine Revenue by Period

Prime Medicine Revenue by Year

DateRevenueChange
2024-12-31$2.98M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31--100.00%
2020-12-31$5.21M100.00%
2019-12-31--

Prime Medicine generated $2.98M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Prime Medicine Revenue by Quarter

DateRevenueChange
2025-06-30$1.11M-23.31%
2025-03-31$1.45M-33.39%
2024-12-31$2.18M944.50%
2024-09-30$209.00K-99.45%
2024-06-30$37.77M6291.54%
2024-03-31$591.00K100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30--100.00%
2021-06-30$9.13M100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2019-12-31--

Prime Medicine generated $1.11M in revenue during Q2 2025, up -23.31% compared to the previous quarter, and up 188.66% compared to the same period a year ago.

Prime Medicine Revenue Breakdown

Prime Medicine Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24
Reportable Segment$2.98M

Prime Medicine's latest annual revenue breakdown by segment (product or service), as of Dec 24: Reportable Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25
Reportable Segment$1.11M$1.45M

Prime Medicine's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Reportable Segment (100.00%).

Prime Medicine Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ADPTAdaptive Bio$178.96M$58.88M
ACLXArcellx$107.94M$8.13M
RXRXRecursion Pharmaceuticals$58.84M$19.22M
VERVVerve Therapeutics$32.33M$13.08M
PRMEPrime Medicine$2.98M$1.11M
SANASana Bio--
CRBUCaribou Biosciences--
THRDThird Harmonic Bio--
BEAMBeam Therapeutics--

PRME Revenue FAQ

What is Prime Medicine’s yearly revenue?

Prime Medicine's yearly revenue for 2024 was $2.98M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. PRME's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Prime Medicine’s quarterly revenue?

Prime Medicine's quarterly revenue for Q2 2025 was $1.12M, a -23.31% decrease from the previous quarter (Q1 2025), and a -97.05% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $1.45M, a -33.39% decrease from the previous quarter (Q4 2024), and a 146.02% increase year-over-year (Q1 2024). PRME's quarterly revenue for Q4 2024 was $2.18M, a 944.50% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023).

What is Prime Medicine’s revenue growth rate?

Prime Medicine's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was -42.74%.

What are Prime Medicine’s revenue streams?

Prime Medicine's revenue streams in c 24 are Reportable Segment

What is Prime Medicine’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Prime Medicine was Reportable Segment. This segment made a revenue of $2.98M, representing 100.00% of the company's total revenue.